Upload Button Icon Add office photos
filter salariesFilter salaries by

Mebita Pharmaceutical Officer salaries in Vapi

Annual salary range
4 - 5 years exp.
₹4.6 Lakhs - ₹5.9 Lakhs
Low Confidence
info icon
Low confidence means that this average salary is based on data that was reported by very few people.
Salary of majority employees
unlock blur
unlock blur

Interested in this particular role?

Last Updated: 16 Mar 2024

Companies similar to Mebita Pharmaceutical for Officer in Vapi

Logo
Mebita Pharmaceutical Officer Salary

4 - 5 years exp. (AmbitionBox Estimate)

unlock blur

₹4.6 L/yr - ₹5.9 L/yr

vs
Company name Avg Annual Salary Open Jobs
Logo
Macleods Pharmaceuticals Officer Salary

1 - 8 years exp. (390 salaries)

unlock blur

₹2 L/yr - ₹5.6 L/yr

arrow icon 27% less
Logo
Sun Pharmaceutical Industries Officer Salary

0 - 7 years exp. (78 salaries)

unlock blur

₹1.8 L/yr - ₹5.7 L/yr

arrow icon 31% less
4 job openings
Logo
Meril Officer Salary

0 - 6 years exp. (69 salaries)

unlock blur

₹1.2 L/yr - ₹3.5 L/yr

arrow icon 56% less
2 job openings
Logo
Umedica Laboratories Officer Salary

0 - 6 years exp. (52 salaries)

unlock blur

₹1 L/yr - ₹3.9 L/yr

arrow icon 51% less
Logo
Welspun Officer Salary

1 - 11 years exp. (50 salaries)

unlock blur

₹2.5 L/yr - ₹6 L/yr

arrow icon 17% less
Officer salary at Mebita Pharmaceutical ranges between ₹4.6 Lakhs to ₹5.9 Lakhs per year for employees with experience between 4 years to 5 years. Salary estimates are based on 2 latest salaries received from various employees of Mebita Pharmaceutical.

Mebita Pharmaceutical Officer Salary FAQs

What is the notice period for Officer at Mebita Pharmaceutical in Vapi?
According to AmbitionBox, 100% of the Mebita Pharmaceutical Officers in Vapi reported a notice period of 3 Months.This is based on 2 responses on AmbitionBox in last 2 years.

Tell us how to improve this page.

Mebita Pharmaceutical Officer salary in Vapi ranges between ₹4.6 Lakhs to ₹5.9 Lakhs. This is an estimate based on latest salaries received from employees of Mebita Pharmaceutical.